WHO ICTRP trial
A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and…
ACTRN12606000316505 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12606000316505 |
|---|---|
| Public title | A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel plus or minus Sorafenib (BAY 43-9006) in chemonaive patients with Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC) Bay 43-9006 / 11961 |
| Scientific title | A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel plus or minus Sorafenib (BAY 43-9006) in chemonaive patients with Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC) |
| Primary sponsor | Bayer Australia Limited |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 / Phase 4 |
| Countries | Australia |
| Conditions | Non-Small Cell Lung Cancer; Non-Small Cell Lung Cancer;Cancer - Lung - Non small cell |
| Interventions | This is a randomized, double blind, placebo controlled, multicenter, Phase III study designed to compare the efficacy of sorafenib in combination with paclitaxel and carboplatin versus placebo in combination with paclitaxel and carboplatin… |
| Registration date | Jul 24, 2006 |
| Target size | 926 |
| Secondary IDs | ClinicalTrials.gov: NCT00300885 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: